MyAverix Finance
SHG · Healthcare
Shanghai Serum Bio-Technology Co. Ltd. A (688163)
Biotechnology
Shanghai Serum Bio-Technology Co. Ltd. A (688163) is listed on SHG in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $2.75B, P/E ratio is 60.50, net margin is 26.4%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 688163
Shanghai Serum Bio-Technology Co. Ltd. A (688163) — FAQ
What is Shanghai Serum Bio-Technology Co. Ltd. A's market cap?
Shanghai Serum Bio-Technology Co. Ltd. A (688163) has a reported market cap of $2.75B (data as of 2026-03-29).
What is 688163's P/E ratio?
The price-to-earnings (P/E) ratio for Shanghai Serum Bio-Technology Co. Ltd. A (688163) is 60.50 (data as of 2026-03-29).
Does Shanghai Serum Bio-Technology Co. Ltd. A pay a dividend?
Dividend yield is not available in the current snapshot for Shanghai Serum Bio-Technology Co. Ltd. A (688163). Check the MyAverix Finance app for the latest dividend data.
What sector is Shanghai Serum Bio-Technology Co. Ltd. A in?
Shanghai Serum Bio-Technology Co. Ltd. A (688163) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 688163 listed on?
688163 is listed on SHG.
What is Shanghai Serum Bio-Technology Co. Ltd. A's net margin?
Shanghai Serum Bio-Technology Co. Ltd. A (688163) reports a net margin of 26.4% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.